KVUE · Kenvue Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.91B | - | $3.76B | $3.84B | $3.74B | - | $3.90B | $4.00B | $3.89B | - |
| Cost of Revenue | $1.61B | - | $1.54B | $1.58B | $1.57B | - | $1.62B | $1.64B | $1.65B | - |
| Gross Profit | $2.30B | - | $2.23B | $2.26B | $2.17B | - | $2.28B | $2.37B | $2.24B | - |
| R&D | $84.00M | - | $94.00M | $91.00M | $99.00M | - | $97.00M | $105.00M | $100.00M | - |
| SG&A | $1.45B | - | $1.51B | $1.50B | $1.54B | - | $1.59B | $1.64B | $1.57B | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $143.00M | - | $182.00M | $141.00M | $136.00M | - | $94.00M | $68.00M | $149.00M | - |
| Operating Income | $767.00M | - | $629.00M | $692.00M | $558.00M | - | $654.00M | $154.00M | $550.00M | - |
| Interest Expense | $106.00M | - | $107.00M | $107.00M | $107.00M | - | $108.00M | $106.00M | $109.00M | - |
| Income Tax | $198.00M | - | $128.00M | $168.00M | $136.00M | - | $194.00M | $7.00M | $131.00M | - |
| Net Income | $474.00M | - | $398.00M | $420.00M | $322.00M | - | $383.00M | $58.00M | $296.00M | - |
| EPS - Basic | $0.25 | - | $0.21 | $0.22 | $0.17 | - | $0.20 | $0.03 | $0.15 | - |
| EPS - Diluted | $0.25 | - | $0.21 | $0.22 | $0.17 | - | $0.20 | $0.03 | $0.15 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.07B | $1.06B | $1.14B | $1.07B | $1.06B | $1.07B | $1.06B | $1.01B | $1.16B | $1.38B |
| Accounts Receivable | $2.50B | $2.38B | $2.42B | $2.33B | $2.31B | $2.17B | $2.39B | $2.24B | $2.16B | $2.07B |
| Inventory | $1.67B | $1.67B | $1.79B | $1.78B | $1.68B | $1.59B | $1.82B | $1.85B | $1.88B | $1.85B |
| Accounts Payable | $2.53B | $2.47B | $2.44B | $2.57B | $2.33B | $2.25B | $2.27B | $2.44B | $2.60B | $2.49B |
| Current Assets | $5.79B | $5.70B | $6.03B | $5.85B | $5.71B | $5.53B | $5.94B | $5.88B | $6.10B | $6.14B |
| Total Assets | $26.85B | $27.08B | $27.25B | $27.13B | $26.26B | $25.60B | $26.93B | $26.44B | $27.28B | $27.85B |
| Current Liabilities | $5.90B | $5.95B | $6.16B | $5.99B | $6.67B | $5.74B | $5.95B | $5.94B | $6.17B | $5.48B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | $7.69B |
| Total Liabilities | $16.25B | $16.31B | $16.61B | $16.40B | $16.20B | $15.93B | $16.28B | $16.27B | $16.66B | $16.64B |
| Stockholders' Equity | $10.61B | $10.77B | $10.63B | $10.73B | $10.05B | $9.67B | $10.64B | $10.18B | $10.62B | $11.21B |
| Retained Earnings | ($128.00M) | ($204.00M) | ($136.00M) | ($136.00M) | ($163.00M) | ($93.00M) | $7.00M | $17.00M | $342.00M | $429.00M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $489.00M | - | - | - | $428.00M | - | - | - | $287.00M | - |
| Investing Cash Flow | ($167.00M) | - | - | - | ($167.00M) | - | - | - | ($152.00M) | - |
| Financing Cash Flow | ($295.00M) | - | - | - | ($310.00M) | - | - | - | ($326.00M) | - |
| CapEx | $139.00M | - | - | - | $179.00M | - | - | - | $153.00M | - |
| Free Cash Flow | $350.00M | - | - | - | $249.00M | - | - | - | $134.00M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 58.9% | - | 59.1% | 58.9% | 58.0% | - | 58.5% | 59.1% | 57.6% | - |
| Operating margin | 19.6% | - | 16.7% | 18.0% | 14.9% | - | 16.8% | 3.9% | 14.1% | - |
| EBITDA margin | 23.3% | - | 21.5% | 21.7% | 18.6% | - | 19.2% | 5.5% | 18.0% | - |
| Net margin | 12.1% | - | 10.6% | 10.9% | 8.6% | - | 9.8% | 1.5% | 7.6% | - |
| Free cash flow margin | 9.0% | - | - | - | 6.7% | - | - | - | 3.4% | - |
| FCF / Net income | 0.74 | - | - | - | 0.77 | - | - | - | 0.45 | - |
| R&D / Revenue | 2.1% | - | 2.5% | 2.4% | 2.6% | - | 2.5% | 2.6% | 2.6% | - |
| SG&A / Revenue | 37.2% | - | 40.2% | 39.2% | 41.1% | - | 40.8% | 41.0% | 40.4% | - |
| Effective tax rate | 29.5% | - | 24.3% | 28.6% | 29.7% | - | 33.6% | 10.8% | 30.7% | - |
| Return on assets | 1.8% | - | 1.5% | 1.5% | 1.2% | - | 1.4% | 0.2% | 1.1% | - |
| Return on equity | 4.5% | - | 3.7% | 3.9% | 3.2% | - | 3.6% | 0.6% | 2.8% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.98 | 0.96 | 0.98 | 0.98 | 0.86 | 0.96 | 1.00 | 0.99 | 0.99 | 1.12 |
| Quick ratio | 0.70 | 0.68 | 0.69 | 0.68 | 0.60 | 0.69 | 0.69 | 0.68 | 0.68 | 0.78 |
| Cash ratio | 0.18 | 0.18 | 0.19 | 0.18 | 0.16 | 0.19 | 0.18 | 0.17 | 0.19 | 0.25 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | 0.69 |
| Debt / Assets | - | - | - | - | - | - | - | - | - | 0.28 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 7.2x | - | 5.9x | 6.5x | 5.2x | - | 6.1x | 1.5x | 5.0x | - |
| Equity multiplier | 2.53 | 2.52 | 2.56 | 2.53 | 2.61 | 2.65 | 2.53 | 2.60 | 2.57 | 2.48 |
| Liabilities / Assets | 0.60 | 0.60 | 0.61 | 0.60 | 0.62 | 0.62 | 0.60 | 0.62 | 0.61 | 0.60 |
| Efficiency | ||||||||||
| Asset turnover | 0.15 | - | 0.14 | 0.14 | 0.14 | - | 0.14 | 0.15 | 0.14 | - |
| Inventory turnover | 0.96 | - | 0.86 | 0.89 | 0.94 | - | 0.89 | 0.88 | 0.88 | - |
| Days sales outstanding | 234d | - | 234d | 222d | 226d | - | 224d | 204d | 202d | - |
| Days inventory outstanding | 380d | - | 426d | 411d | 390d | - | 411d | 413d | 416d | - |
| Days payable outstanding | 575d | - | 580d | 594d | 541d | - | 513d | 544d | 575d | - |
| Cash conversion cycle | 38d | - | 80d | 38d | 74d | - | 122d | 73d | 44d | - |
| Valuation | ||||||||||
| P / E | 70.1x | - | 78.2x | 94.9x | 139.4x | - | 116.3x | 606.0x | 143.1x | - |
| P / B | 3.2x | - | 3.0x | 3.8x | 4.5x | - | 4.2x | 3.4x | 3.9x | - |
| P / S | 8.6x | - | 8.4x | 10.5x | 12.2x | - | 11.5x | 8.7x | 10.6x | - |
| EV / EBITDA | 35.8x | - | 37.5x | 47.0x | 64.2x | - | 58.4x | 152.7x | 57.3x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 4.5% | - | -3.5% | -4.0% | -3.9% | - | 2.9% | 5.2% | 8.5% | - |
| Revenue CAGR (3y) | 2.9% | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 6.2% | - | -2.5% | -4.4% | -3.3% | - | 1.4% | 6.3% | 14.6% | - |
| Operating income growth (YoY) | 37.5% | - | -3.8% | 349.4% | 1.5% | - | -7.9% | -78.1% | -14.1% | - |
| Net income growth (YoY) | 47.2% | - | 3.9% | 624.1% | 8.8% | - | -34.6% | -86.5% | -10.3% | - |
| EPS growth (YoY) | 47.1% | - | 5.0% | 633.3% | 13.3% | - | -41.2% | -87.0% | -51.6% | - |
| EPS CAGR (3y) | -6.9% | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 40.6% | - | - | - | 85.8% | - | - | - | -55.5% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 5.5% | 11.3% | -0.1% | 5.4% | -5.3% | -13.8% | -43.7% | -48.1% | -47.6% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-28.
Business segments
$15.12B totalSelf Care$6.38B · 42.2%
Essential Health$4.63B · 30.6%
Skin Health And Beauty$4.11B · 27.2%
Geographic
$21.58B totalNorth America$7.26B · 33.6%
US$6.46B · 29.9%
EMEA$3.72B · 17.2%
Asia Pacific$2.77B · 12.9%
Latin America$1.37B · 6.3%
Peer comparison
Same SIC group: Perfumes, Cosmetics & Other Toilet Preparations
Comparing Kenvue Inc. against the 5 most active filers in the same SIC group.
Dividends
$0.83/share trailing 12 months · +1.5% YoY
| Ex-date | Per share |
|---|---|
| May 13, 2026 | $0.2080 |
| Feb 11, 2026 | $0.2080 |
| Nov 12, 2025 | $0.2080 |
| Aug 13, 2025 | $0.2080 |
| May 14, 2025 | $0.2050 |
| Feb 12, 2025 | $0.2050 |
| Nov 13, 2024 | $0.2050 |
| Aug 14, 2024 | $0.2050 |
| May 7, 2024 | $0.2000 |
| Feb 13, 2024 | $0.2000 |
| Nov 7, 2023 | $0.2000 |
| Aug 25, 2023 | $0.2000 |